Atorvastatin reduces cardiac and adipose tissue inflammation in rats with metabolic syndrome
- 1 August 2017
- journal article
- Published by Elsevier in International Journal of Cardiology
- Vol. 240, 332-338
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Statin treatment and new-onset diabetes: A review of proposed mechanismsMetabolism, 2014
- AMP-activated protein kinase inhibits NF-κB signaling and inflammation: impact on healthspan and lifespanJournal of Molecular Medicine, 2011
- The Inflammation Hypothesis and Its Potential Relevance to Statin TherapyThe American Journal of Cardiology, 2007
- Statins Activate AMP-Activated Protein Kinase In Vitro and In VivoCirculation, 2006
- Pitavastatin Improves Cardiac Function and Survival in Association With Suppression of the Myocardial Endothelin System in a Rat Model of Hypertensive Heart FailureJournal of Cardiovascular Pharmacology, 2006
- Pravastatin increases survival and suppresses an increase in myocardial matrix metalloproteinase activity in a rat model of heart failureCardiovascular Research, 2006
- Atorvastatin induces insulin sensitization in Zucker lean and fatty ratsAtherosclerosis, 2006
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialThe Lancet, 2002
- The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals.Nature Medicine, 2000
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995